0000000000021973

AUTHOR

Pierre-benoit Pagès

showing 15 related works from this author

Les réadmissions après résection pulmonaire en France : la base de données du PMSI

2021

BACKGROUND Readmission within 30 days is an indicator of the quality of care, because it often reflects post-discharge care that is not optimal. The objective of this work is to measure over time on the one hand the readmission rate and on the other hand the number of hospitals with a standardized readmission rate beyond the national average. METHOD All patients with major pulmonary resection for lung cancer in France were extracted from the PMSI national database. Readmission within 30 days was defined as any new hospitalization either in the same hospital or in another establishment. RESULTS From January 1, 2005 to December 31, 2018, 110,603 patients were included. The 30-day all-cause re…

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industrymedicine.medical_treatmentmedicine.diseaseReadmission rate3. Good health03 medical and health sciencesPneumonectomy0302 clinical medicine030228 respiratory systemEmergency medicinemedicineNational database030212 general & internal medicineNational averageLung resectionPulmonary resectionQuality of careLung cancerbusinessRevue des Maladies Respiratoires
researchProduct

Mesure de la qualité des soins à partir de la base de données nationale du PMSI. Étude de la mortalité hospitalière après résections pulmonaires pour…

2016

Introduction En 2009, les centres prenant en charge des cancers ont ete soumis a autorisation suite au premier plan cancer. Cinq annees plus tard, il nous paraissait interessant de connaitre l’impact de cette nouvelle organisation. L’objectif est d’estimer l’effet periode et d’evaluer l’influence du volume d’activite sur la mortalite. Methodes De la base de donnees PMSI ont ete extraits pour tous les patients ayant eu une resection pulmonaire pour cancer bronchique. Les caracteristiques des centres comprennent le volume d’activite annuel et le type d’etablissement : publiques non universitaires, prives et CHU. L’indicateur de qualite utilise est la mortalite hospitaliere definie comme tout …

EpidemiologyPublic Health Environmental and Occupational HealthRevue d'Épidémiologie et de Santé Publique
researchProduct

Does age over 80 years have to be a contraindication for lung cancer surgery—a nationwide database study

2018

IF 1.804 (2017); International audience; Background: Nowadays surgery remains the best treatment for localized lung cancer (LC). However, patients over 80 years old are often denied surgery because of the postoperative risk of death. This study aimed to estimate in-hospital mortality (IHM) and determine whether age over 80 is the most important predictor of IHM after LC surgery.Methods: From January 2005 to December 2015, 97,440 patients, including 4,438 patients over 80 years old, were operated on for LC and recorded in the French Administrative Database. Characteristics of patients, hospitals and surgery were analysed.Results: Crude IHM was 3.73% (n=3,639) and 7.77% (n=345) for the over 8…

Pulmonary and Respiratory Medicinemedicine.medical_specialtylobectomypredictive factors[SDV.CAN]Life Sciences [q-bio]/Cancer030230 surgery03 medical and health sciencesLiver disease0302 clinical medicinePostoperative riskmedicineLung cancerContraindicationLung cancer surgerybusiness.industryOver 80sNationwide databasein-hospital mortality (IHM)medicine.diseaseSublobar resection3. Good healthSurgeryOriginal ArticlePulmonary resectionbusinessnationwide database
researchProduct

Évaluation de la pratique chirurgicale dans le traitement du cancer bronchique en France à partir de la base nationale du PMSI

2019

Background - In recent years, improving the quality of care has been a concern for health professionals in France, through the certification of institutions, accreditation and continuous professional development. Evaluation of these different measures has rarely been carried out. The objective of the study was to evaluate the quality of surgical management of lung cancer in different regions using hospital mortality as an indicator. Method - From the national database of the Program of Medical Information Systems (PMSI), data on all patients who had undergone surgery for lung cancer were extracted as well as the characteristics of the centers. The main outcome criterion was hospital mortali…

Pulmonary and Respiratory MedicineVolume d’activitésmedicine.medical_specialtyGrippe[SDV.CAN]Life Sciences [q-bio]/CancerEpidémie saisonnière03 medical and health sciences0302 clinical medicineHospital volumeBase de données nationales médico-administrative[SDV.CAN] Life Sciences [q-bio]/Cancermedicine030212 general & internal medicineChirurgieGynecologybusiness.industryRisk standardized rate of mortalityPMSI3. Good healthHospital volumeTaux standardisé de mortalité030228 respiratory systemCancer du poumonNational databaseFranceLung cancerbusinessHôpitalSurgery Medico-administrative database
researchProduct

Le pneumocytome sclérosant : une tumeur rare et apparemment bénigne

2020

International audience; Introduction: Sclerosing pneumocytoma is a benign and rare lung tumor affecting epithelial cells. In most cases, patients are asymptomatic and the diagnosis is made on an X ray or a CT scan performed for other enquiry. Sex ratio favors women. Epidemiological studies report that middle-aged Asian women are more frequently affected. Radiological investigations find a solitary nodule or a mass with peripheric localization. When performed, histological analysis shows a tumor composed of at least two of the four following architectures: papillary, sclerosing, hemangiomatous and solid, with two types of cells that can be round or cubic cells.Cases report: We report two cas…

Pulmonary and Respiratory MedicineGynecologymedicine.medical_specialtybusiness.industryRare tumor[SDV]Life Sciences [q-bio]Sclerosing pneumocytomaBenign tumormedicine.diseaseSclerosing pneumocytoma030218 nuclear medicine & medical imagingBenign tumor[SDV] Life Sciences [q-bio]03 medical and health sciencesRare tumorLung nodules0302 clinical medicine030220 oncology & carcinogenesisSclerosing hemangiomamedicinebusiness
researchProduct

Quelle place reste-t-il pour la chirurgie dans les cancers bronchiques de stade IIIA-N2 ?

2015

Resume Introduction Le cancer bronchique non a petites cellules (CBNPC) demeure un probleme de sante majeur, avec une survie globale a 5 ans des stades IIIA de l’ordre de 25 %. La prise en charge chirurgicale des CBNPC de stade IIIA demeure cependant controversee. Nous avons donc evalue les differentes strategies de prise en charge des CBNPC de stade IIIA-N2. Methodes De janvier 1990 a decembre 2013, les essais controles randomises evaluant la survie des patients traites par chimiotherapie d’induction suivie d’une resection chirurgicale vs chirurgie seule, et ceux evaluant la survie des patients traites par radio- ou chimiotherapie d’induction suivie d’une resection chirurgicale vs la combi…

Pulmonary and Respiratory MedicineGynecologymedicine.medical_specialtybusiness.industrymedicineNon small cellStage IIIaLung cancermedicine.diseasebusinessRevue des Maladies Respiratoires
researchProduct

Hospital Readmission after Major Pulmonary Resection for Lung Cancer in France: A Nationwide Medico-Administrative Database

2019

Objectives: After major pulmonary resection for lung cancer, hospital readmission is considered an indicator of the quality of care. Our main objective was to define the readmission rate at 30 days after pulmonary resection. Secondary objectives were to determine the causes and predictive factors. Methods: Data for all patients operated for lung cancer were extracted from the national medico-administrative database of the Programme de Medicalisation des Systemes d'Information (PMSI). Thirty-days hospital readmission was defined as any new hospitalization within 30 days after discharge from the surgical department following major lung resection, regardless of the reason for readmission. Resu…

medicine.medical_specialtybusiness.industryDiseaseOdds ratiomedicine.diseaseConfidence intervalSepsisMalnutritionRespiratory failureEmergency medicineMedicinebusinessComplicationLung cancerSSRN Electronic Journal
researchProduct

Acute and delayed toxicity of gemcitabine administered during isolated lung perfusion: a preclinical dose-escalation study in pigs.

2014

BACKGROUND: Colorectal cancer is the third most commonly diagnosed cancer worldwide, with up to 25% of patients presenting with metastases at the time of diagnosis. Despite pulmonary metastasectomy many patients go on to develop pulmonary recurrence, which might be linked to the presence of lung micrometastases. In this setting, the adjuvant administration of high-dose chemotherapy by isolated lung perfusion (ILP) has shown encouraging results. However, the tolerance to and efficacy of modern gemcitabine (GEM)-based chemotherapy regimens during adjuvant ILP remain unknown. We conducted a dose-escalating preclinical study to evaluate the immediate and delayed toxicity of GEM in a pig model t…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyAntimetabolites AntineoplasticLung Neoplasmsendocrine system diseasesPulmonary toxicityIsolated lung perfusionmedicine.medical_treatmentAcute Lung InjurySus scrofaDrug Evaluation PreclinicalAnesthesia GeneralGastroenterologyDeoxycytidineInternal medicinemedicineAnimalsLungChemotherapyLungDose-Response Relationship Drugbusiness.industryGeneral MedicineChemotherapy regimenGemcitabineGemcitabineDisease Models Animalmedicine.anatomical_structureAnesthesiaChemotherapy Cancer Regional PerfusionToxicityAcute DiseaseSurgeryFemaleMetastasectomyCardiology and Cardiovascular Medicinebusinessmedicine.drugEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
researchProduct

Is an activity volume threshold really realistic for lung cancer resection?

2018

IF 1.804 (2017); International audience; Background:We analyzed volume as a continuous variable to estimate threshold, which is a methodology rarely seen in the literature. The objective of this work was to assess hospital volume for lung cancer (LC) surgery and to establish the associated threshold for acceptable in-hospital mortality (IHM). Data was obtained from the French national medico-administrative database.Methods:From January 2005 to December 2016, data from 108,571 patients operated for LC in France were collected from the national administrative database. To estimate the volume threshold, hierarchical logistic regression models were developed.Results:The crude IHM rate was 5.2% …

Pulmonary and Respiratory Medicinemedicine.medical_specialty[SDV.CAN]Life Sciences [q-bio]/Cancer030204 cardiovascular system & hematologyLung cancer (LC)Logistic regressionOddssurgery03 medical and health scienceshospital volume0302 clinical medicineHospital volumethresholdmedicineLung cancerbusiness.industryin-hospital mortality (IHM)Odds ratiomedicine.diseaseConfidence interval3. Good health030228 respiratory systemCardiothoracic surgeryEmergency medicineOriginal ArticlebusinessVolume (compression)Journal of Thoracic Disease
researchProduct

Guidelines on enhanced recovery after pulmonary lobectomy

2021

International audience; Objective : To establish recommendations for optimisation of the management of patients undergoing pulmonary lobectomy, particularly Enhanced Recovery After Surgery (ERAS).Design : A consensus committee of 13 experts from the French Society of Anaesthesia and Intensive Care Medicine (Soci,t, franOaise d'anesth,sie et de r,animation, SFAR) and the French Society of Thoracic and Cardiovascular Surgery (Soci,t, franOaise de chirurgie thoracique et cardiovasculaire, SFCTCV) was convened. A formal conflict-of-interest policy was developed at the onset of the process and enforced throughout. The entire guidelines process was conducted independently of any industry funding.…

medicine.medical_specialtyIndustry fundingmedicine.medical_treatmentPopulationCritical Care and Intensive Care Medicine03 medical and health sciences0302 clinical medicineEnhanced recovery030202 anesthesiologyPulmonary lobectomyMedicineguidelinesGrading (education)educationeducation.field_of_studyRehabilitationbusiness.industrypulmonary lobectomyenhanced recovery after surgery (ERAS)General surgery030208 emergency & critical care medicineGeneral MedicineGuidelineEvidence-based medicine3. Good healthAnesthesiology and Pain Medicinebusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Validation and update of the thoracic surgery scoring system (Thoracoscore) risk model.

2020

Abstract OBJECTIVES The performance of prediction models tends to deteriorate over time. The purpose of this study was to update the Thoracoscore risk prediction model with recent data from the Epithor nationwide thoracic surgery database. METHODS From January 2016 to December 2017, a total of 56 279 patients were operated on for mediastinal, pleural, chest wall or lung disease. We used 3 recommended methods to update the Thoracoscore prediction model and then proceeded to develop a new risk model. Thirty-day hospital mortality included patients who died within the first 30 days of the operation and those who died later during the same hospital stay. RESULTS We compared the baseline patient…

Pulmonary and Respiratory MedicineLung Diseasesmedicine.medical_specialtyCalibration (statistics)030204 cardiovascular system & hematologyOverfittingRisk Assessment03 medical and health sciencesRisk model0302 clinical medicineGoodness of fitRisk FactorsmedicineThoracoscopyHumansHospital MortalityAgedPerformance statusmedicine.diagnostic_testbusiness.industryThoracic SurgeryGeneral MedicineThoracic Surgical Procedures030228 respiratory systemROC CurveCardiothoracic surgeryEmergency medicineSurgeryCardiology and Cardiovascular MedicinebusinessPredictive modellingEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
researchProduct

Impact of video-assisted thoracic surgery approach on postoperative mortality after lobectomy in octogenarians.

2019

The number of octogenarians who present with localized lung cancer eligible for surgical resection is increasing. Video-assisted thoracic surgery lobectomy has been widely accepted, but the potential benefit in octogenarians is not well established, especially for postoperative mortality. This study aimed to assess the impact of a video-assisted thoracic surgery approach on postoperative mortality after lobectomy for lung cancer in octogenarians.From January 2005 to December 2016, all patients aged more than 80 years who received lobectomy treatment for lung cancer were retrieved from the French Administrative Database. The end point was 30-day postoperative death. A propensity score was ge…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyLung NeoplasmsTime FactorsDatabases Factualmedicine.medical_treatment[SDV]Life Sciences [q-bio]030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicineRisk FactorsThoracoscopyMedicineHumansThoracotomyLung cancerPneumonectomyComputingMilieux_MISCELLANEOUSAged 80 and overmedicine.diagnostic_testbusiness.industryThoracic Surgery Video-AssistedAge FactorsOdds ratiomedicine.diseaseConfidence intervalSurgeryTreatment Outcome030228 respiratory systemThoracotomyCardiothoracic surgeryPostoperative mortalityPropensity score matchingSurgeryFemaleFranceCardiology and Cardiovascular MedicinebusinessThe Journal of thoracic and cardiovascular surgery
researchProduct

Chirurgie des métastases pulmonaires des cancers colorectaux : facteurs prédictifs de survie

2016

Resume Introduction Le cancer colorectal represente la 3e cause de mortalite par cancer : 5 % des patients vont developper des metastases pulmonaires. Le concept de chirurgie des cancers oligometastatiques est base sur l’objectif d’un controle local optimal de la maladie. Etat des connaissances A ce jour, aucun essai controle randomise ne valide la chirurgie de resection des metastases pulmonaires des patients oligometastatiques porteurs d’un cancer colorectal controle localement. Cependant, de nombreuses series, le plus souvent retrospectives, rapportent des survies prolongees chez des patients tres selectionnes, allant de 45 a 65 % a 5 ans dans les series les plus recentes. Les facteurs c…

Pulmonary and Respiratory MedicineGynecology03 medical and health sciencesmedicine.medical_specialty0302 clinical medicinebusiness.industry030220 oncology & carcinogenesisMultimodality Treatmentmedicine030204 cardiovascular system & hematologybusinessRevue des Maladies Respiratoires
researchProduct

Isolated Lung Perfusion as an Adjuvant Treatment of Colorectal Cancer Lung Metastases: A Preclinical Study in a Pig Model

2012

BackgroundThe lung is a frequent site of colorectal cancer (CRC) metastases. After surgical resection, lung metastases recurrences have been related to the presence of micrometastases, potentially accessible to a high dose chemotherapy administered via adjuvant isolated lung perfusion (ILP). We sought to determine in vitro the most efficient drug when administered to CRC cell lines during a short exposure and in vivo its immediate and delayed tolerance when administered via ILP.MethodsFirst, efficacy of various cytotoxic molecules against a panel of human CRC cell lines was tested in vitro using cytotoxic assay after a 30-minute exposure. Then, early (operative) and delayed (1 month) tolera…

OncologyCardiothoracic SurgeryPathologyLung NeoplasmsSwineColorectal cancerIsolated lung perfusionmedicine.medical_treatmentCancer TreatmentCardiovascularDeoxycytidineMetastasischemistry.chemical_compoundDrug DistributionMultidisciplinaryQRThoracic SurgeryPerfusionTreatment OutcomeSurgical Oncologymedicine.anatomical_structureOncologyChemotherapy AdjuvantMedicineDeoxycytidineColorectal NeoplasmsAdjuvantResearch ArticleDrugs and Devicesmedicine.medical_specialtyScienceAntineoplastic AgentsIn vivoCell Line TumorInternal medicinemedicineAnimalsHumansPulmonary Vascular DiseasesPharmacokineticsAnalysis of VarianceChemotherapyLungDose-Response Relationship Drugbusiness.industryHemodynamicsChemotherapy and Drug Treatmentmedicine.diseaseGemcitabineDrug LiberationchemistryVasoconstrictionSurgerybusinessPLoS ONE
researchProduct

In-hospital mortality following lung cancer resection: nationwide administrative database.

2016

Our aim was to determine the effect of a national strategy for quality improvement in cancer management (the “Plan Cancer”) according to time period and to assess the influence of type and volume of hospital activity on in-hospital mortality (IHM) within a large national cohort of patients operated on for lung cancer.From January 2005 to December 2013, 76 235 patients were included in the French Administrative Database. Patient characteristics, hospital volume of activity and hospital type were analysed over three periods: 2005–2007, 2008–2010 and 2011–2013.Global crude IHM was 3.9%: 4.3% during 2005–2007, 4% during 2008–2010 and 3.5% during 2011–2013 (p<0.01). 296, 259 and 209 centres p…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyPathologyLung NeoplasmsSurvivalDatabases FactualMEDLINEOperative Mortality030204 cardiovascular system & hematologyResectionCohort Studies03 medical and health sciences0302 clinical medicineAdministrative databaseInternal medicineMedicineHumansHospital MortalityLung cancerPneumonectomyLungAgedIn hospital mortalitybusiness.industryVolumeData CollectionCancerMiddle Agedmedicine.diseaseQualityHospitalsManagementComorbidity IndexHospitalization030228 respiratory systemOutcome IndicatorsCancer managementLobectomySurgeryFemaleFranceTrendsbusiness[ SDV.MHEP.PSR ] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tractCohort studyThe European respiratory journal
researchProduct